Relationship between chronic kidney disease and metabolic syndrome: current perspectives

被引:60
作者
Nashar, Khaled [1 ]
Egan, Brent M. [2 ,3 ]
机构
[1] Allegheny Gen Hosp, Div Nephrol & Hypertens, 320 E North Ave, Pittsburgh, PA 15212 USA
[2] Care Coordinat Inst, Greenville, SC 29601 USA
[3] Greenville Hlth Syst, Greenville, SC 29605 USA
关键词
obesity; insulin resistance; hypertension; oxdative stress; inflammation; adipokines;
D O I
10.2147/DMSO.S45183
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Both metabolic syndrome (MetS) and chronic kidney disease (CKD) are increasing in incidence and lead to significant cardiovascular morbidity and mortality. The relationship between these two entities is complex. Individual components of the MetS are known risk factors for incident kidney disease, but it is not clear how the clustering of these components is linked to the development and progression of kidney disease. Cross-sectional studies show an association of the MetS and prevalent CKD; however, one cannot draw conclusions as to which came first - the MetS or the kidney disease. Observational studies suggest a relationship between MetS and incident CKD, but they also demonstrate the development of MetS in patients with established CKD. These observations suggest a bidirectional relationship. A better understanding of the relationship between components of the MetS and whether and how these components contribute to progression of CKD and incident cardiovascular disease could inform more effective prevention strategies.
引用
收藏
页码:421 / 435
页数:15
相关论文
共 115 条
[1]   RELATIONSHIPS OF GENERALIZED AND REGIONAL ADIPOSITY TO INSULIN SENSITIVITY IN MEN [J].
ABATE, N ;
GARG, A ;
PESHOCK, RM ;
STRAYGUNDERSEN, J ;
GRUNDY, SM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) :88-98
[2]  
Agrawal S, 2012, CARDIOL RES PRACT, V2012
[3]   Impact of treating the metabolic syndrome on chronic kidney disease [J].
Agrawal, Varun ;
Shah, Aashish ;
Rice, Casey ;
Franklin, Barry A. ;
McCullough, Peter A. .
NATURE REVIEWS NEPHROLOGY, 2009, 5 (09) :520-528
[4]   Insulin resistance and altered glucose transporter 4 expression in experimental uremia [J].
Aksentijevic, Dunja ;
Bhandari, Sunil ;
Seymour, Anne-Marie L. .
KIDNEY INTERNATIONAL, 2009, 75 (07) :711-718
[5]   The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[6]   Kidney Pathological Changes in Metabolic Syndrome: A Cross-sectional Study [J].
Alexander, Mariam P. ;
Patel, Tejas V. ;
Farag, Youssef M. K. ;
Florez, Adriana ;
Rennke, Helmut G. ;
Singh, Ajay K. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (05) :751-759
[7]   Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population [J].
Athyros, Vasilios G. ;
Ganotakis, Emmanuel S. ;
Tziomalos, Konstantinos ;
Papageorgiou, Athanasios A. ;
Anagnostis, Panagiotis ;
Griva, Theodora ;
Kargiotis, Konstantinos ;
Mitsiou, Eydoxia K. ;
Karagiannis, Asterios ;
Mikhailidis, Dimitri P. .
CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (03) :713-719
[8]   Metabolic syndrome: a fata morgana? [J].
Bakker, Stephan J. L. ;
Gansevoort, Ron T. ;
de Zeeuw, Dick .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (01) :15-20
[9]   Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: The mild and moderate kidney disease study [J].
Becker, B ;
Kronenberg, F ;
Kielstein, JT ;
Haller, H ;
Morath, C ;
Ritz, E ;
Fliser, D .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (04) :1091-1098
[10]   Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the Southeastern United States, Part II: Treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome [J].
Bestermann, W ;
Houston, MC ;
Basile, J ;
Egan, B ;
Ferrario, CM ;
Lackland, D ;
Hawkins, RG ;
Reed, J ;
Rogers, P ;
Wise, D ;
Moore, MA .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2005, 329 (06) :292-305